FOS and cancer: An early study discovered that E2 induces fatty acid synthase expression in ER-negative CRC cells and CAFs through GPER-mediated activation of the EGFR/ERK/c-Fos/AP1 signaling pathway, stimulating cancer cell proliferation and migration [117] (Fig. 4).